All Stories

  1. IL‐9 Is Essential for ILC2‐Mediated but Not Th2‐ and Th17‐Cell‐Mediated Allergic Airway Inflammation in Mice
  2. RNA-LNP–mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I
  3. IL-33-induced ILC2 effector cytokine responses promote the expansion of red pulp macrophages
  4. The phospholipid profile of T cells shapes ACSL4 dependency and ferroptosis sensitivity of naive, effector, and memory T cells
  5. Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses
  6. GM-CSF derived from alveolar type 2 cells promotes CD301b + cDC2 generation and allergic airway inflammation
  7. IL-6 mediates defense against influenza virus by promoting protective antibody responses but not innate inflammation
  8. Treatment of a metabolic liver disease in mice with a transient prime editing approach
  9. Peroxisomes are critical for a unique metabolic demand and survival of alveolar macrophages
  10. Investigating Polyreactivity of CD4 + T Cells to the Intestinal Microbiota
  11. IL-1 protects from fatal systemic candidiasis in mice by inhibiting oxidative phosphorylation and hypoxia
  12. Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma
  13. An Nrf2-NF-κB Crosstalk Controls Hepatocyte Proliferation in the Normal and Injured Liver
  14. IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy
  15. Endothelial metabolic control of insulin sensitivity through resident macrophages
  16. Inflammatory Mediators Suppress FGFR2 Expression in Human Keratinocytes to Promote Inflammation
  17. Effective genome editing with an enhanced ISDra2 TnpB system and deep learning-predicted ωRNAs
  18. A guideline on the molecular ecosystem regulating ferroptosis
  19. Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes
  20. The role of recruitment versus training in influenza-induced lasting changes to alveolar macrophage function
  21. Data from A Protumorigenic mDia2–MIRO1 Axis Controls Mitochondrial Positioning and Function in Cancer-Associated Fibroblasts
  22. Supplementary Data from A Protumorigenic mDia2–MIRO1 Axis Controls Mitochondrial Positioning and Function in Cancer-Associated Fibroblasts
  23. Supplementary Figure from A Protumorigenic mDia2–MIRO1 Axis Controls Mitochondrial Positioning and Function in Cancer-Associated Fibroblasts
  24. Supplementary Figure from A Protumorigenic mDia2–MIRO1 Axis Controls Mitochondrial Positioning and Function in Cancer-Associated Fibroblasts
  25. The thioredoxin system: Balancing redox responses in immune cells and tumors
  26. A Protumorigenic mDia2–MIRO1 Axis Controls Mitochondrial Positioning and Function in Cancer-Associated Fibroblasts
  27. Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection
  28. High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape
  29. LCMV induced downregulation of HVEM on antiviral T cells is critical for an efficient effector response
  30. Gene therapy of Csf2ra deficiency in mouse fetal monocyte precursors restores alveolar macrophage development and function
  31. Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing
  32. KappaBle fluorescent reporter mice enable low-background single-cell detection of NF-κB transcriptional activity in vivo
  33. In vivo prime editing of a metabolic liver disease in mice
  34. Peroxisomes Are Critical for the Development and Maintenance of B1 and Marginal Zone B Cells but Dispensable for Follicular B Cells and T Cells
  35. Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosis
  36. Intercrypt sentinel macrophages tune antibacterial NF-κB responses in gut epithelial cells via TNF
  37. Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis
  38. Cytomegalovirus subverts macrophage identity
  39. GM-CSF instigates a dendritic cell–T-cell inflammatory circuit that drives chronic asthma development
  40. Tissue-resident macrophages: guardians of organ homeostasis
  41. PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
  42. PPARγ is essential for the development of bone marrow erythroblastic island macrophages and splenic red pulp macrophages
  43. Comparative analysis of the role of mast cells in murine asthma models using Kit‐sufficient mast cell‐deficient animals
  44. Redox regulation of immunometabolism
  45. The thioredoxin‐1 inhibitor Txnip restrains effector T‐cell and germinal center B‐cell expansion
  46. The GM-CSF–IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses
  47. Electrophilic Nrf2 activators and itaconate inhibit inflammation at low dose and promote IL-1β production and inflammatory apoptosis at high dose
  48. High-Dimensional T Helper Cell Profiling Reveals a Broad Diversity of Stably Committed Effector States and Uncovers Interlineage Relationships
  49. Endothelial Lactate Controls Muscle Regeneration from Ischemia by Inducing M2-like Macrophage Polarization
  50. Comprehensive characterization of myeloid cells during wound healing in healthy and healing‐impaired diabetic mice
  51. Mice carrying an analogous heterozygous dynamin 2 K562E mutation that causes neuropathy in humans develop predominant characteristics of a primary myopathy
  52. Cyclopentenone Prostaglandins and Structurally Related Oxidized Lipid Species Instigate and Share Distinct Pro- and Anti-inflammatory Pathways
  53. Thioredoxin-1 distinctly promotes NF-κB target DNA binding and NLRP3 inflammasome activation independently of Txnip
  54. Fetal monocytes possess increased metabolic capacity and replace primitive macrophages in tissue macrophage development
  55. Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
  56. B1 and Marginal Zone B Cells but Not Follicular B2 Cells Require Gpx4 to Prevent Lipid Peroxidation and Ferroptosis
  57. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
  58. Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction
  59. A spontaneous leptin receptor point mutation causes obesity and differentially affects leptin signaling in hypothalamic nuclei resulting in metabolic dysfunctions distinct from db/db mice
  60. Glutathione peroxidase 4 and vitamin E control reticulocyte maturation, stress erythropoiesis and iron homeostasis
  61. IL-21 promotes allergic airway inflammation by driving apoptosis of FoxP3+ regulatory T cells
  62. Author Correction: Deciphering CD4+ T cell specificity using novel MHC–TCR chimeric receptors
  63. GM-CSF intrinsically controls eosinophil accumulation in the setting of allergic airway inflammation
  64. Deciphering CD4+ T cell specificity using novel MHC–TCR chimeric receptors
  65. The thioredoxin‐1 and glutathione/glutaredoxin‐1 systems redundantly fuel murine B‐cell development and responses
  66. Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
  67. PPAR-γ in innate and adaptive lung immunity
  68. The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell metabolic reprogramming and proliferation
  69. Synthesis and Structure–Activity Relationship Studies of Anti-Inflammatory Epoxyisoprostane Analogues
  70. Training myeloid precursors with fungi, bacteria and chips
  71. Regulatory T cells are required for normal and activin‐promoted wound repair in mice
  72. Inhibition of Poxvirus Gene Expression and Genome Replication by Bisbenzimide Derivatives
  73. PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation
  74. Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10
  75. Frontline Science: Coincidental null mutation of Csf2rα in a colony of PI3Kγ−/− mice causes alveolar macrophage deficiency and fatal respiratory viral infection
  76. PI3Kγ Is Critical for Dendritic Cell-Mediated CD8+ T Cell Priming and Viral Clearance during Influenza Virus Infection
  77. PI3-Kinase-γ Has a Distinct and Essential Role in Lung-Specific Dendritic Cell Development
  78. Total Synthesis of Prostaglandin 15d-PGJ2 and Investigation of its Effect on the Secretion of IL-6 and IL-12
  79. tEMPting Fate MaYBe the Solution
  80. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection
  81. Phospholipid oxidation generates potent anti‐inflammatory lipid mediators that mimic structurally related pro‐resolving eicosanoids by activating Nrf2
  82. Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease
  83. The development and function of lung-resident macrophages and dendritic cells
  84. Discovery of a Highly Potent Anti-inflammatory Epoxyisoprostane-Derived Lactone
  85. Influenza A virus uses the aggresome processing machinery for host cell entry
  86. Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
  87. Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages
  88. Endothelial cells translate pathogen signals into G-CSF–driven emergency granulopoiesis
  89. Alveolar Macrophages Are Essential for Protection from Respiratory Failure and Associated Morbidity following Influenza Virus Infection
  90. TREM-1 Deficiency Can Attenuate Disease Severity without Affecting Pathogen Clearance
  91. Cell-wall deficient L. monocytogenes L-forms feature abrogated pathogenicity
  92. Fatty acid–induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis
  93. Innate Signaling Promotes Formation of Regulatory Nitric Oxide–Producing Dendritic Cells Limiting T-Cell Expansion in Experimental Autoimmune Myocarditis
  94. IL-21 Restricts Virus-driven Treg Cell Expansion in Chronic LCMV Infection
  95. Synthesis of Epoxyisoprostanes: Effects in Reducing Secretion of Pro‐inflammatory Cytokines IL‐6 and IL‐12
  96. Lymphocyte development
  97. The origin and fate of γδT cell subsets
  98. Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk
  99. Cooperation of T h1 and T h17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy
  100. Cutting Edge: LPS-Induced Emergency Myelopoiesis Depends on TLR4-Expressing Nonhematopoietic Cells
  101. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
  102. Evidence for the divergence of innate and adaptive T-cell precursors before commitment to the αβ and γδ lineages
  103. Cre-Mediated Cell Ablation Contests Mast Cell Contribution in Models of Antibody- and T Cell-Mediated Autoimmunity
  104. Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis
  105. HVEM Signalling Promotes Colitis
  106. Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism
  107. IL-21 induces death of marginal zone B cells during chronic inflammation
  108. IL-17A/F-Signaling Does Not Contribute to the Initial Phase of Mucosal Inflammation Triggered by S. Typhimurium
  109. Averting inflammation by targeting the cytokine environment
  110. Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner
  111. Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice
  112. Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis
  113. A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
  114. A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
  115. Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal
  116. The Kinase Activity of Rip2 Determines Its Stability and Consequently Nod1- and Nod2-mediated Immune Responses
  117. Role of GM-CSF signaling in cell-based tumor immunization
  118. IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection
  119. IL-17–producing T cells in lung immunity and inflammation
  120. CD40–CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4 + T cells
  121. GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survival
  122. IL‐21 and IL‐21R are not required for development of Th17 cells and autoimmunity in vivo
  123. Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury
  124. Effective T-cell immune responses in the absence of the serine/threonine kinase RIP2
  125. T-cell fate and function: PKC-θ and beyond
  126. Nippostrongylus brasiliensis infection leads to the development of emphysema associated with the induction of alternatively activated macrophages
  127. Toll-like receptors: paving the path to T cell-driven autoimmunity?
  128. IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance
  129. Dyslipidemia inhibits Toll-like receptor–induced activation of CD8α-negative dendritic cells and protective Th1 type immunity
  130. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo
  131. Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis
  132. Vaccination against IL‐17 suppresses autoimmune arthritis and encephalomyelitis
  133. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation
  134. Distinct roles for IL‐6 and IL‐12p40 in mediating protection against Leishmania donovani and the expansion of IL‐10+ CD4+ T cells
  135. ABERRANT ACUTE-PHASE RESPONSE IN AGED INTERLEUKIN-6 KNOCKOUT MICE
  136. Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6
  137. The osteopontin – CD44 pathway is superfluous for the development of autoimmune myocarditis
  138. Chemokines: more than just road signs
  139. Innate signals compensate for the absence of PKC-θ duringin vivoCD8+ T cell effector and memory responses
  140. Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection
  141. IL‐4Rα signaling is important for CD8+ T cell cytotoxicity in the absence of CD4+ T cell help
  142. CCL19 and CCL21 Induce a Potent Proinflammatory Differentiation Program in Licensed Dendritic Cells
  143. Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1
  144. Mechanisms of autoimmune heart disease
  145. Models of autoimmune heart disease
  146. Allergic airway inflammation is exacerbated during acute influenza infection and correlates with increased allergen presentation and recruitment of allergen‐specific T‐helper type 2 cells
  147. Protein Kinase C θ Is Critical for the Development of In Vivo T Helper (Th)2 Cell But Not Th1 Cell Responses
  148. Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells
  149. IL-6 is required for glioma development in a mouse model
  150. Maintenance of memory CTL responses by T helper cells and CD40‐CD40 ligand: antibodies provide the key
  151. Maintenance of memory CTL responses by T helper cells and CD40‐CD40 ligand: antibodies provide the key
  152. Dendritic cell–induced autoimmune heart failure requires cooperation between adaptive and innate immunity
  153. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis
  154. A role for antibodies in the generation of memory antifungal immunity
  155. The IL‐1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model
  156. Activation of Dendritic Cells through the Interleukin 1 Receptor 1 Is Critical for the Induction of Autoimmune Myocarditis
  157. Interleukin-6–Deficient Mice Resist Development of Autoimmune Myocarditis Associated With Impaired Upregulation of Complement C3
  158. Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia
  159. Balancing protective immunity and immunopathology
  160. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
  161. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection
  162. A high-throughput alphavirus-based expression cloning system for mammalian cells
  163. Retarded Liver Growth in Interleukin-6-Deficient and Tumor Necrosis Factor Receptor-1-Deficient Mice
  164. IL‐5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation
  165. Severe Schistosomiasis in the Absence of Interleukin-4 (IL-4) Is IL-12 Independent
  166. Inducible Costimulator Protein (Icos) Controls T Helper Cell Subset Polarization after Virus and Parasite Infection
  167. Lipopolysaccharide-induced HIV-1 expression in transgenic mice is mediated by tumor necrosis factor-α and interleukin-1, but not by interferon-γ nor interleukin-6
  168. Antifungal type 1 responses are upregulated in IL-10-deficient mice
  169. Interleukin‐4 Causes Susceptibility to Invasive Pulmonary Aspergillosis through Suppression of Protective Type I Responses
  170. Cd2 Sets Quantitative Thresholds in T Cell Activation
  171. Schistosoma mansoni: IL-4 Is Necessary for Concomitant Immunity in Mice
  172. CD8+ T Cells Mediate CD40-independent Maturation of Dendritic Cells In Vivo
  173. Developmental Regulation of Lck Targeting to the CD8 Coreceptor Controls Signaling in Naive and Memory T Cells
  174. Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro
  175. Interleukin 6 Influences Germinal Center Development and Antibody Production via a Contribution of C3 Complement Component
  176. Interleukin 6 plays a key role in the development of antigen-induced arthritis
  177. Induction of Gut Mucosal Immune Responses: Importance of Genetic Background and Th1/Th2 Cross‐Regulation
  178. Endogenous Interleukin 4 Is Required for Development of Protective CD4+ T Helper Type 1 Cell Responses to Candida albicans
  179. Costimulation through B7-2 (CD86) Is Required for the Induction of a Lung Mucosal T Helper Cell 2 (TH2) Immune Response and Altered Airway Responsiveness
  180. Cytokines and infectious diseases
  181. Lymphocyte subsets in experimental bronchopulmonary inflammation and hyperresponsiveness
  182. Lipopolysaccharide-sensitivity of interferon-γ receptor deficient mice
  183. Distinct Tumorigenic Potential of abl and raf in B Cell Neoplasia: abl Activates the IL-6 Signaling Pathway
  184. IL-5-Deficient Mice Have a Developmental Defect in CD5+ B-1 Cells and Lack Eosinophilia but Have Normal Antibody and Cytotoxic T Cell Responses
  185. Innate versus acquired immunity in listeriosis
  186. Mouse Eotaxin Expression Parallels Eosinophil Accumulation during Lung Allergic Inflammation but It Is Not Restricted to a Th2-Type Response
  187. Schistosoma mansoni in IL-4-deficient mice
  188. Immune Responses of IL‐4, IL‐5, IL‐6 Deficient Mice
  189. Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness).
  190. Interleukin 6 is essential for in vivo development of B lineage neoplasms.
  191. Pleiotropic Defects of IL‐6—deficient Mice Including Early Hematopoiesis, T and B Cell Function, and Acute Phase Responses
  192. B-cell maturation in chimaeric mice deficient for the heat stable antigen (HSA/mouse CD24)
  193. Impaired mucosal immune responses in interleukin 4-targeted mice.
  194. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system
  195. The immune response to Plasmodium chabaudi malaria in interleukin‐4‐deficient mice